Toggle menu

TPTIH

Start date:
August 2015
End date:
Predicted September 2017
Co-ordinated by:
The University of Nottingham

To establish genetic associations between patients with thiazide-induced hyponatraemia and patients taking a thiazide who did not develop hyponatraemia.

Eligibility criteria

Inclusion criteria:

  • Age 18-100 years
  • Have the capacity to give informed consent
  • Be taking a thiazide or thiazide-related diuretic unless in the non-thiazide control group
  • Plasma sodium concentration of less than 130 mM for cases and between 135 mM and 145 mM for controls

Local PI

Dr Ann Lockman

Consultant in Acute Medicine

Research Team

Julia Grahamslaw

Lead Research Nurse

Caroline Blackstock

AMU Senior Research Nurse

Bev Goldberg

AMU Senior Research Nurse

Rachel O'Brien

Lead Research Nurse

More EMERGE Trials

MAPP2

The Markers and Paracetamol Poisoning Study 2

Molecular and cellular analysis of intracranial tumours

Read more

BRAINED

Molecular and cellular analysis of intracranial tumours

TARGET CTCA is a joint venture between EMERGE and the cardiology research team aiming to recruit patients with suspected ACS across NHS Lothian and NHS Greater Glasgow and Clyde. The study aims to recruit 2270 participants. For further information, please contact the EMERGE team.

Read more

TARGET-CTCA